Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR
PHASE2CompletedINTERVENTIONAL
Enrollment
57
Participants
Timeline
Start Date
June 30, 1998
Study Completion Date
June 30, 2004
Conditions
LeukoplakiaPeriodontal Disease
Interventions
DRUG
Ketorolac Rinse
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001698 - Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR | Biotech Hunter | Biotech Hunter